|
1
|
Michaeli D, Hecht JR, Oortgiesen M, Eduljee A, Perkins WD, Ajani JA. Final data of the multicenter phase II study of cisplatin (CDDP) and 5-fluorouracil (5-FU) in combination with G17DT Immunogen in chemonaive patients with locally recurrent or metastatic gastric and gastroesophageal cancer. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.4048] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- D. Michaeli
- Aphton Corporation, Woodland, CA; UCLA School of Medicin, Los Angeles, CA; Cato Research, Durham, NC; MD Anderson Cancer Center, Houston, TX
| | - J. R. Hecht
- Aphton Corporation, Woodland, CA; UCLA School of Medicin, Los Angeles, CA; Cato Research, Durham, NC; MD Anderson Cancer Center, Houston, TX
| | - M. Oortgiesen
- Aphton Corporation, Woodland, CA; UCLA School of Medicin, Los Angeles, CA; Cato Research, Durham, NC; MD Anderson Cancer Center, Houston, TX
| | - A. Eduljee
- Aphton Corporation, Woodland, CA; UCLA School of Medicin, Los Angeles, CA; Cato Research, Durham, NC; MD Anderson Cancer Center, Houston, TX
| | - W. D. Perkins
- Aphton Corporation, Woodland, CA; UCLA School of Medicin, Los Angeles, CA; Cato Research, Durham, NC; MD Anderson Cancer Center, Houston, TX
| | - J. A. Ajani
- Aphton Corporation, Woodland, CA; UCLA School of Medicin, Los Angeles, CA; Cato Research, Durham, NC; MD Anderson Cancer Center, Houston, TX
| |
Collapse
|